Development of a CRISPR/Cas12a‐recombinase polymerase amplification assay for visual and highly specific identification of the Congo Basin and West African strains of mpox virus
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Xinggui Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, P.R. China. Hauptthemen laut MEDLINE: Recombinases, CRISPR-Cas Systems. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Guizhou Science and Technology Department.
Abstract (Originalsprache)
Human mpox is a zoonotic disease, similar to smallpox, caused by the mpox virus, which is further subdivided into Congo Basin and West African clades with different pathogenicity. In this study, a novel diagnostic protocol utilizing clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated 12a nuclease (CRISPR/Cas12a)‐mediated recombinase polymerase amplification (RPA) was developed to identify mpox in the Congo Basin and West Africa (CRISPR‐RPA). Specific RPA primers targeting D14L and ATI were designed. CRISPR‐RPA assay was performed using various target templates. In the designed CRISPR‐RPA reaction system, the exponentially amplified RPA amplification products with a protospacer adjacent motif (PAM) site can locate the Cas12a/crRNA complex to its target regions, which successfully activates the CRISPR/Cas12a effector and achieves ultrafast trans ‐cleavage of a single‐stranded DNA probe. The limit of detection for the CRISPR‐RPA assay was 10 copies per reaction for D14L‐ and ATI ‐plasmids. No cross‐reactivity was observed with non‐mpox strains, confirming the high specificity of the CRISPR‐RPA assay for distinguishing between the Congo Basin and West African mpox. The CRISPR‐RPA assay can be completed within 45 min using real‐time fluorescence readout. Moreover, the cleavage results were visualized under UV light or an imaging system, eliminating the need for a specialized apparatus. In summary, the developed CRISPR/RPA assay is a visual, rapid, sensitive, and highly specific detection technique that can be used as an attractive potential identification tool for Congo Basin and West African mpox in resource‐limited laboratories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, P.R. China.
- The Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, P.R. China.
- Experimental Research Center, Capital Institute of Pediatrics, Beijing, P.R. China.
ORCID-Profile: Xinggui Yang, Yi Wang
Förderung
- Guizhou Science and Technology Department
Zitieren
APA
Yang, X., Zeng, X., Chen, X., Huang, J., Wei, X., Ying, X., Tan, Q., Wang, Y., & Li, S. (2023). Development of a CRISPR/Cas12a‐recombinase polymerase amplification assay for visual and highly specific identification of the Congo Basin and West African strains of mpox virus. Journal of Medical Virology. https://doi.org/10.1002/jmv.28757
Vancouver
Yang X, Zeng X, Chen X, Huang J, Wei X, Ying X, et al. Development of a CRISPR/Cas12a‐recombinase polymerase amplification assay for visual and highly specific identification of the Congo Basin and West African strains of mpox virus. Journal of Medical Virology. 2023. doi:10.1002/jmv.28757
BibTeX
@article{Yang2023,
author = {Yang, Xinggui and Zeng, Xiaoyan and Chen, Xu and Huang, Junfei and Wei, Xiaoyu and Ying, Xia and Tan, Qinqin and Wang, Yi and Li, Shijun},
title = {Development of a CRISPR/Cas12a‐recombinase polymerase amplification assay for visual and highly specific identification of the Congo Basin and West African strains of mpox virus},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28757}
}
EUVIMED